Misplaced Pages

This is the current revision of this page, as edited by Boghog (talk | contribs) at 19:39, 30 October 2023 (consistent citation formatting). The present address (URL) is a permanent link to this version.

Xibornol

Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	J01XX02 (WHO)
Identifiers
IUPAC name 4,5-dimethyl-2-heptanyl]phenol
CAS Number	13741-18-9
PubChem CID	11777299
DrugBank	DB13714
ChemSpider	9951982
UNII	RQ12GMY0FZ
KEGG	D07433
ChEBI	CHEBI:131713
ChEMBL	ChEMBL2104519
CompTox Dashboard (EPA)	DTXSID60472406
ECHA InfoCard	100.033.906
Chemical and physical data
Formula	C18H26O
Molar mass	258.405 g·mol
3D model (JSmol)	Interactive image
SMILES Oc1cc(c(cc1C2CC3CCC2(C)C3(C)C)C)C
InChI InChI=1S/C18H26O/c1-11-8-14(16(19)9-12(11)2)15-10-13-6-7-18(15,5)17(13,3)4/h8-9,13,15,19H,6-7,10H2,1-5H3 Key:RNRHMQWZFJXKLZ-UHFFFAOYSA-N
(verify)

Xibornol is a lipophilic substance with antiseptic properties, mainly used in Italy and Spain. It is primarily administered to the throat as a spray mouthwash. As of 2007, all approved forms are water-based suspensions.

The drug was discovered in the 1970s.

References

1. Cirri M, Mura P, Mora PC (August 2007). "Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems". International Journal of Pharmaceutics. 340 (1–2): 84–91. doi:10.1016/j.ijpharm.2007.03.021. PMID 17531411.
2. Celandroni F, Mazzantini D, Calvigioni M, Ceccanti S, Vecchiani S, Battaglia S, et al. (2022). "Antimicrobial Activity of Xibornol and a Xibornol-Based Formulation Against Gram-Positive Pathogens of the Respiratory Tract". Advances in Microbiology, Infectious Diseases and Public Health. Advances in Experimental Medicine and Biology. Vol. 1369. pp. 101–106. doi:10.1007/5584_2021_664. hdl:11568/1115592. ISBN 978-3-031-01994-4. PMID 34387849. S2CID 236998271.

This systemic antibiotic-related article is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Antibiotics
• Phenols
• Antibiotic stubs